에프리노멕틴

용도

• Treatment and prevention of fleas, ticks, nematodes (including feline lungworm and Capillaria plica), and prevention of heartworm disease
• Treatment of psoroptic (P. equi) mange
• Ear mites (Psoroptes cuniculi) in rabbits
• Labeled indications (gastrointestinal roundworms, cattle grubs, lice, mange mites, horn flies, lungworms)

투여 방법

가능한 부작용

• Ineffectiveness for parasite control (reported in FDA database)
• Anorexia
• Udder hypogalactia
• Mild clumping of the hair at the application site

주의사항 및 금기

• Oral administration
• Intravenous administration
• Cats weighing < 0.6 kg
• Kittens < 7 weeks of age
• Dogs (not intended for use)
• > **Warning:** Do not administer orally or intravenously. Highly toxic to fish and aquatic organisms; dispose of containers properly.

약물 상호작용

• ciclosporin: Potential interaction as both are P-glycoprotein substrates; none reported clinically
• itraconazole: Potential interaction as both are P-glycoprotein substrates; none reported clinically
• loperamide: Potential interaction as both are P-glycoprotein substrates; none reported clinically
• steroids: Potential interaction as both are P-glycoprotein substrates; none reported clinically
• opiates: Potential interaction as both are P-glycoprotein substrates; none reported clinically
• P-glycoprotein substrates (e.g., ciclosporin, itraconazole, loperamide, steroids, opiates): Theoretical potential for interaction due to shared P-glycoprotein efflux pump mechanisms, though none have been clinically reported.

자주 묻는 질문